Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Patel

Showing results (181-190 of 213) with videos related to

Pageof 22
Sort By:
Molecular Medicine (Cambridge, Mass.)|July 1, 2020
The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulationRavikumar A Sitapara, Alex G Gauthier, Sergio I Valdés-Ferrer, et al.
Frontiers in Immunology|March 9, 2026
Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experienceNaimisha Marneni, Spencer Lessans, Bhagirathbhai Dholaria, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 18, 2025
Evaluation of an Oxygenator in the EXTra-Uterine Environment for Neonatal Development (EXTEND) System Without Systemic AnticoagulationSeitaro Kosaka, Urgyen Wangmo, Marina Heffelfinger, et al.
Frontiers in Cardiovascular Medicine|November 7, 2022
The safety of early discharge following transfemoral transcatheter aortic valve replacement under general anesthesiaOfir Koren, Vivek Patel, Siamak Kohan, et al.
JACC. Advances|January 28, 2026
Bicuspid Aortic Valve Leaflet Modification Before Transcatheter Aortic Valve Replacement: A New ParadigmHasan Jilaihawi, Martin B Leon, Roy D Dar, et al.
Molecular Medicine (Cambridge, Mass.)|September 4, 2021
Correction to: 2‑O, 3‑O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1‑compromised macrophage functionMao Wang, Alex G Gauthier, Thomas P Kennedy, et al.
Molecular Medicine (Cambridge, Mass.)|July 17, 2021
2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage functionMao Wang, Alex G Gauthier, Thomas P Kennedy, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
New adverse coronary events in valve-in-valve TAVR and native TAVR-A 2-year matched cohortOfir Koren, Vivek Patel, Robert Naami, et al.
American Heart Journal|January 4, 2025
Implications of an off-hours setting in patients undergoing transcatheter edge-to-edge repair for mitral regurgitationAlon Shechter, Aakriti Gupta, Danon Kaewkes, et al.
Cardiovascular Intervention and Therapeutics|December 15, 2025
One-year outcomes of the RESILIA balloon-expandable transcatheter valve: survival, hemodynamics, and hypoattenuated leaflet thickeningKazuki Suruga, Vivek Patel, Yuchao Guo, et al.
Pageof 22

Showing results (181-190 of 213) with videos related to

Sort By:
Pageof 22
Molecular Medicine (Cambridge, Mass.)|July 1, 2020
The α7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulationRavikumar A Sitapara, Alex G Gauthier, Sergio I Valdés-Ferrer, et al.
Frontiers in Immunology|March 9, 2026
Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experienceNaimisha Marneni, Spencer Lessans, Bhagirathbhai Dholaria, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 18, 2025
Evaluation of an Oxygenator in the EXTra-Uterine Environment for Neonatal Development (EXTEND) System Without Systemic AnticoagulationSeitaro Kosaka, Urgyen Wangmo, Marina Heffelfinger, et al.
Frontiers in Cardiovascular Medicine|November 7, 2022
The safety of early discharge following transfemoral transcatheter aortic valve replacement under general anesthesiaOfir Koren, Vivek Patel, Siamak Kohan, et al.
JACC. Advances|January 28, 2026
Bicuspid Aortic Valve Leaflet Modification Before Transcatheter Aortic Valve Replacement: A New ParadigmHasan Jilaihawi, Martin B Leon, Roy D Dar, et al.
Molecular Medicine (Cambridge, Mass.)|September 4, 2021
Correction to: 2‑O, 3‑O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1‑compromised macrophage functionMao Wang, Alex G Gauthier, Thomas P Kennedy, et al.
Molecular Medicine (Cambridge, Mass.)|July 17, 2021
2-O, 3-O desulfated heparin (ODSH) increases bacterial clearance and attenuates lung injury in cystic fibrosis by restoring HMGB1-compromised macrophage functionMao Wang, Alex G Gauthier, Thomas P Kennedy, et al.
Frontiers in Cardiovascular Medicine|October 10, 2022
New adverse coronary events in valve-in-valve TAVR and native TAVR-A 2-year matched cohortOfir Koren, Vivek Patel, Robert Naami, et al.
American Heart Journal|January 4, 2025
Implications of an off-hours setting in patients undergoing transcatheter edge-to-edge repair for mitral regurgitationAlon Shechter, Aakriti Gupta, Danon Kaewkes, et al.
Cardiovascular Intervention and Therapeutics|December 15, 2025
One-year outcomes of the RESILIA balloon-expandable transcatheter valve: survival, hemodynamics, and hypoattenuated leaflet thickeningKazuki Suruga, Vivek Patel, Yuchao Guo, et al.
Pageof 22